Suppr超能文献

纳米颗粒药物递送系统的溶出度测试策略:最新进展与挑战

Dissolution Testing Strategies for Nanoparticulate Drug Delivery Systems: Recent Developments and Challenges.

作者信息

Shen Jie, Burgess Diane J

机构信息

Department of Pharmaceutical Sciences, University of Connecticut, 69 North Eagleville Road U 3092, Storrs, CT 06269, USA.

出版信息

Drug Deliv Transl Res. 2013 Oct 1;3(5):409-415. doi: 10.1007/s13346-013-0129-z.

Abstract

Nanoparticulate systems have emerged as prevalent drug delivery systems over the past few decades. These delivery systems (such as liposomes, emulsions, nanocrystals, and polymeric nanocarriers) have been extensively used to improve bioavailability, prolong pharmacological effects, achieve targeted drug delivery, as well as reduce side effects. Considering that any unanticipated change in product performance of such systems may result in toxicity and/or change efficacy, it is essential to develop suitable dissolution/release testing methods to ensure product quality and performance, and to assist in product development. The present review provides an overview of the current dissolution/release testing methods such as dialysis, sample and separate, as well as continuous flow methods. Challenges and future directions in the development of standardized and biorelevant dissolution/release testing methods for novel nanoparticulate systems are discussed.

摘要

在过去几十年中,纳米颗粒系统已成为普遍的药物递送系统。这些递送系统(如脂质体、乳剂、纳米晶体和聚合物纳米载体)已被广泛用于提高生物利用度、延长药理作用、实现靶向给药以及减少副作用。鉴于此类系统产品性能的任何意外变化都可能导致毒性和/或疗效改变,开发合适的溶出/释放测试方法以确保产品质量和性能,并协助产品开发至关重要。本综述概述了当前的溶出/释放测试方法,如透析法、取样分离法以及连续流动法。还讨论了新型纳米颗粒系统标准化和生物相关性溶出/释放测试方法开发中的挑战和未来方向。

相似文献

1
Dissolution Testing Strategies for Nanoparticulate Drug Delivery Systems: Recent Developments and Challenges.
Drug Deliv Transl Res. 2013 Oct 1;3(5):409-415. doi: 10.1007/s13346-013-0129-z.
2
In vitro dissolution considerations associated with nano drug delivery systems.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Nov;13(6):e1732. doi: 10.1002/wnan.1732. Epub 2021 Jun 15.
3
In-vitro dissolution methods for controlled release parenterals and their applicability to drug-eluting stent testing.
J Pharm Pharmacol. 2012 Jul;64(7):969-85. doi: 10.1111/j.2042-7158.2011.01439.x. Epub 2012 Feb 7.
5
Role of In Vitro Release Methods in Liposomal Formulation Development: Challenges and Regulatory Perspective.
AAPS J. 2017 Nov;19(6):1669-1681. doi: 10.1208/s12248-017-0142-0. Epub 2017 Sep 18.
6
In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation.
J Control Release. 2017 Mar 28;250:86-95. doi: 10.1016/j.jconrel.2016.12.043. Epub 2017 Jan 27.
10
A novel USP apparatus 4 based release testing method for dispersed systems.
Int J Pharm. 2010 Mar 30;388(1-2):287-94. doi: 10.1016/j.ijpharm.2010.01.009. Epub 2010 Jan 18.

引用本文的文献

2
Vanadium ferrite-doped mesoporous bioactive glass-ceramics: controlled cisplatin delivery in chemohyperthermia.
RSC Adv. 2025 Jun 3;15(23):18657-18669. doi: 10.1039/d5ra01999k. eCollection 2025 May 29.
10
GLP-1 Analogue-Loaded Glucose-Responsive Nanoparticles as Allies of Stem Cell Therapies for the Treatment of Type I Diabetes.
ACS Pharmacol Transl Sci. 2024 May 2;7(5):1650-1663. doi: 10.1021/acsptsci.4c00173. eCollection 2024 May 10.

本文引用的文献

1
Drug release from nanomedicines: Selection of appropriate encapsulation and release methodology.
Drug Deliv Transl Res. 2012 Aug;2(4):284-92. doi: 10.1007/s13346-012-0064-4. Epub 2012 Mar 3.
2
Analytical methods for dissolution testing of nanosized drugs.
J Pharm Pharmacol. 2012 Jul;64(7):931-43. doi: 10.1111/j.2042-7158.2012.01520.x. Epub 2012 May 2.
3
Is dialysis a reliable method for studying drug release from nanoparticulate systems?-A case study.
Int J Pharm. 2012 Sep 15;434(1-2):28-34. doi: 10.1016/j.ijpharm.2012.05.020. Epub 2012 May 19.
4
A two-stage reverse dialysis in vitro dissolution testing method for passive targeted liposomes.
Int J Pharm. 2012 Apr 15;426(1-2):211-218. doi: 10.1016/j.ijpharm.2012.01.030. Epub 2012 Jan 23.
5
Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings.
Int J Pharm. 2012 Jan 17;422(1-2):341-8. doi: 10.1016/j.ijpharm.2011.10.020. Epub 2011 Oct 13.
6
Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation.
AAPS PharmSciTech. 2011 Dec;12(4):1087-101. doi: 10.1208/s12249-011-9675-1. Epub 2011 Aug 31.
7
Modeling drug-carrier interaction in the drug release from nanocarriers.
J Drug Deliv. 2011;2011:370308. doi: 10.1155/2011/370308. Epub 2011 Aug 10.
9
USP apparatus 4 method for in vitro release testing of protein loaded microspheres.
Int J Pharm. 2011 May 16;409(1-2):178-84. doi: 10.1016/j.ijpharm.2011.02.057. Epub 2011 Mar 3.
10
Online monitoring of dissolution tests using dedicated potentiometric sensors in biorelevant media.
Eur J Pharm Biopharm. 2011 May;78(1):158-65. doi: 10.1016/j.ejpb.2010.12.014. Epub 2010 Dec 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验